|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: IMMUCELL CORP /DE/, 10-Q, EX-10.1, 2000-11-13 |
Next: NORTHEAST BANCORP /ME/, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMPANY'S
UNAUDITED FINANCIAL STATEMENTS FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2000
AS REPORTED ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 1,940,531
<SECURITIES> 0
<RECEIVABLES> 618,134
<ALLOWANCES> 39,285
<INVENTORY> 708,258
<CURRENT-ASSETS> 3,289,037
<PP&E> 1,724,649
<DEPRECIATION> 959,836
<TOTAL-ASSETS> 4,285,940
<CURRENT-LIABILITIES> 454,717
<BONDS> 419,488
0
0
<COMMON> 3,411,735
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 4,285,940
<SALES> 3,933,034
<TOTAL-REVENUES> 4,043,489
<CGS> 1,969,375
<TOTAL-COSTS> 3,810,502
<OTHER-EXPENSES> (73,803)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 28,825
<INCOME-PRETAX> 277,965
<INCOME-TAX> 0
<INCOME-CONTINUING> 277,965
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 277,965
<EPS-BASIC> 0.11
<EPS-DILUTED> 0.10
</TABLE>
|
|